These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2437719)

  • 21. [Drug therapy of chronic arterial occlusion of the extremities by intraarterial administration of Verapramil].
    Nissen P; Alexander K; Nedden KH; Fabel H
    Dtsch Med Wochenschr; 1972 Sep; 97(35):1288-91. PubMed ID: 5050240
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial ischaemia and reperfusion in the anaesthetised pig: reduction of infarct size and myocardial enzyme release by the stable prostacyclin analogue iloprost.
    Stürzebecher S; McDonald FM; Grundmann G; Hartmann S; Lammert C
    Prog Clin Biol Res; 1989; 301():155-9. PubMed ID: 2477850
    [No Abstract]   [Full Text] [Related]  

  • 23. [An evaluation of the results of intra-arterial injections in treating chronic ischemia of the lower extremities].
    Prokhorov GG
    Vestn Khir Im I I Grek; 1991; 147(7-8):41-4. PubMed ID: 1668930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasorelaxation in prostacyclin-hyperpolarized arterial smooth musculature.
    Siegel G; Schnalke F; Stock G
    Prog Clin Biol Res; 1989; 301():441-7. PubMed ID: 2477857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of iloprost on acute myocardial ischemia in dogs.
    Ieda N; Matsubara T; Sakamoto N
    Nagoya J Med Sci; 1994 Mar; 57(1-4):25-33. PubMed ID: 7534870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intra-arterial and intravenous Complamine therapy].
    Musil HE
    Med Welt; 1973 Nov; 24(45):1759-61. PubMed ID: 4768209
    [No Abstract]   [Full Text] [Related]  

  • 27. PGE1 and iloprost affect the high energy phosphates in the global ischemic and reperfused rat heart: a 31P-NMR study.
    Pissarek M; Gründer W; Keller T; Lindenau KF; Krause EG
    Biomed Biochim Acta; 1989; 48(1):43-50. PubMed ID: 2476119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the PG-analogues iloprost, nalador and nileprost on rejection time and TXB2 content of murine tail skin allografts.
    Becker K; Lueddeckens G; von Baehr R; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S117-20. PubMed ID: 2470350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts.
    Smith EF; Kloster G; Stöcklin G; Schrör K
    Biomed Biochim Acta; 1984; 43(8-9):S155-8. PubMed ID: 6083784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins.
    Fitscha P; Kaliman J; O'Grady J; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):443-6. PubMed ID: 2465949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of iloprost on spreading of ischaemic necrosis in the hairless mouse ear.
    Müller B; Schmidtke M
    Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):63-4. PubMed ID: 1692631
    [No Abstract]   [Full Text] [Related]  

  • 32. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group.
    Beischer W; Dembski JC; Gruss JD; Hofgärtner F; Horsch A; Horsch S; Kuhlmann HW; Loose DA; Mietaschk A; Schwilden ED; Spengel F; Spitzer W; Staben P; Stallkamp B; Stürzebecher CS; Tokhi M; von Bilderling P
    Vasa; 1998 Feb; 27(1):15-9. PubMed ID: 9540427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
    Cowley AJ; Heptinstall S; Hampton JR
    Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological effects of iloprost (ZK 36 374), a stable prostacyclin analogue, in man.
    Ylitalo P; Kaukinen S; Seppäla E; Nurmi AK; Pessi T; Krais T; Vapaatalo H
    Biomed Biochim Acta; 1984; 43(8-9):S399-402. PubMed ID: 6083786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alpha blocking properties of dihydro ergot derivatives. Findings on skin and muscle temperature].
    D'Ayala Valva G; Dabizzi RP; Banchelli A
    Riv Crit Clin Med; 1967 Aug; 67(3):191-9. PubMed ID: 4395433
    [No Abstract]   [Full Text] [Related]  

  • 38. Transdermally applied iloprost (ZK36-374) decreases whole blood platelet aggregation in normal volunteers.
    Belch JJ; Ansell D; Saniabadi A; Forbes CD; Sturrock RD
    Prog Clin Biol Res; 1987; 242():413-7. PubMed ID: 2444992
    [No Abstract]   [Full Text] [Related]  

  • 39. [Investigation by borrowing-lending-phenomenon under conditions of intraarterial induced vasodilatation (author's transl)].
    Hänsgen K; Preuss EG; Podhaisky H; Seige K
    Z Kardiol; 1977 Sep; 66(9):511-5. PubMed ID: 919679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Müller B; Maass B; Stürzebecher S; Skuballa W
    Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.